EpCAM expression is also related to CD44 and CD166, and the triple-positive (EpCAM+/CD44+/CD166+) markers in NSCLC indicate higher self-renewal ability, clonal heterogeneity, and stemness-associated gene expression (33). Here, ALCAM is linked to non-small cell lung carcinoma.